Stay updated on Sub-Lingual Dexmedetomidine in Agitation Clinical Trial
Sign up to get notified when there's something new on the Sub-Lingual Dexmedetomidine in Agitation Clinical Trial page.

Latest updates to the Sub-Lingual Dexmedetomidine in Agitation Clinical Trial page
- Check5 days agoChange DetectedThe page shows a minor revision update to v3.4.2 and removal of the prior government funding notice (v3.4.1), with no impact on the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check12 days agoChange DetectedAdded a government funding status notice at the top of the page informing users about potential delays and current site status. Updated the site revision label from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check19 days agoChange DetectedUI text changes include a glossary toggle label and capitalization tweaks for QC-related fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data); a new page revision tag (Revision: v3.4.0) was introduced. The study content and data remain unchanged.SummaryDifference0.2%

- Check33 days agoChange DetectedDifference0.1%

- Check55 days agoChange Detected- Locations are consolidated under a single Locations section listing Florida, Massachusetts, Michigan, and New Jersey; the previous location sections and the HHS Vulnerability Disclosure link were removed, and the revision label updated to v3.3.3.SummaryDifference0.5%

- Check83 days agoChange DetectedThe Publications section wording was updated to clarify that PubMed-sourced publications may not pertain to the study, and the revision label was updated to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Sub-Lingual Dexmedetomidine in Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sub-Lingual Dexmedetomidine in Agitation Clinical Trial page.